EUVIMEDEUVIMED entdecken
Open Access

Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome

Vamsidhar Veeranki iD, Jeyakumar Meyyappan, Arpit Srivastava, Ravi Shanker Kushwaha, Manas Behera, Manas Ranjan Patel, Anupma Kaul, Dharmendra Singh Bhadauria, Monika Yachha, Manoj Jain, Jai Kishun, Narayan Prasad

Indian Journal of Nephrology · 2024

DOI: 10.25259/ijn_106_2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Nephrology, 2024. Verfasst von Vamsidhar Veeranki und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atypical hemolytic uremic syndrome (aHUS) is a severe thrombotic microangiopathy predominantly affecting the kidneys, often associated with complement dysregulation. This study is aimed to analyze the clinical characteristics, treatment outcomes, and long-term implications of aHUS in a resource-limited setting. Materials and Methods A retrospective observational study conducted at an institute between January 2016 and December 2022 included all patients with aHUS, excluding secondary causes and renal transplant recipients. Demographic profiles, clinical features, laboratory parameters, treatment modalities (immunosuppression and plasma exchange), and outcomes were collected. Anticomplement Factor H (anti-CFH) antibody, complement levels, and genetic mutation analysis were performed to ascertain etiological factors. The patient and renal outcomes of anti-CFH positive and negative patients on long-term follow-up were compared.

Results

Fifty-seven patients (mean age: 12.5 ± 4.9 years; 63% males) were analyzed. Among them, 33 (57.9%) tested positive for anti-CFH antibodies and eight presented postpartum. Initial remission was achieved in 42 (73.6%) patients, with 13 (22.8%) partial and 29 (50.9%) complete remission. The median follow-up duration was 24 months [interquartile range (IQR) 8.5–84]; 12 (21%) patients died, with two deaths during the index admission, six among nonresponders, and 4 among responders. Dialysis-free renal survival was superior in anti-CFH seropositive patients (81.2%) compared to seronegative counterparts (55.9%), while patient survival was statistically similar between the two groups. Elevated anti-CFH titers (>4000 AU/ml), age ≥16 years, female gender, and seizures predicted nonresponsiveness.

Conclusion

Anti-CFH antibody associated aHUS had better kidney outcomes than the seronegative counterparts. In resource limited settings, a combination of plasma exchange and immunosuppression showed promising results in the short and long term.

Schlagwörter

Stichwörter der Autor:innen

Anti-CFH antibodyAtypical HUSLong-term outcomesPlasmapheresisThrombotic microangiopathy

Autor:innen und Institutionen

  • Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
  • Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
  • Department of Biostatistics, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.

ORCID-Profile: Vamsidhar Veeranki

Zitieren

APA

Veeranki, V., Meyyappan, J., Srivastava, A., Kushwaha, R. S., Behera, M., Patel, M. R., Kaul, A., Bhadauria, D. S., Yachha, M., Jain, M., Kishun, J., & Prasad, N. (2024). Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome. Indian Journal of Nephrology. https://doi.org/10.25259/ijn_106_2024

Vancouver

Veeranki V, Meyyappan J, Srivastava A, Kushwaha RS, Behera M, Patel MR, et al. Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome. Indian Journal of Nephrology. 2024. doi:10.25259/ijn_106_2024

BibTeX
@article{Veeranki2024,
  author = {Veeranki, Vamsidhar and Meyyappan, Jeyakumar and Srivastava, Arpit and Kushwaha, Ravi Shanker and Behera, Manas and Patel, Manas Ranjan and Kaul, Anupma and Bhadauria, Dharmendra Singh and Yachha, Monika and Jain, Manoj and Kishun, Jai and Prasad, Narayan},
  title = {Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome},
  journal = {Indian Journal of Nephrology},
  year = {2024},
  doi = {10.25259/ijn_106_2024}
}
Kostenlos starten →